Sort

Search

01/04/2022 Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents
Mendez, I, Sintes, A, Pascual, JC, Punti, J, Lara, A, Briones-Buixassa, L, Nicolaou, S, Schmidt, C, Romero, S, Fernandez, M, Farres, CCI, Soler, J, Santamarina-Perez, P, Vega, D. Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302DOI:10.1016/j.jad.2022.01.065. PMID:35038480. IF:6.600(Q1/2D).
01/04/2022 Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?
Amoretti, S, Verdolini, N, Varo, C, Mezquida, G, Sanchez-Torres, AM, Vieta, E, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Abregu-Crespo, R, Corripio, I, Serra, M, de la Serna, E, Mane, A, Ramos-Quiroga, JA, Ribases, M, Cuesta, MJ, Bernardo, M. Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302DOI:10.1016/j.jad.2022.01.077. PMID:35066012. IF:6.600(Q1/2D).
01/04/2022 The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
Martínez-Pinteño A., Mezquida G., Bioque M., López-Ilundain J.M., Andreu-Bernabeu Á., Zorrilla I., Mané A., Rodríguez-Jiménez R., Corripio I., Sarró S., Ibáñez Á., Usall J., Rivero O., Gassó P., Leza J.C., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Mas S., Bernardo M., Amoretti S., Morén C., Urbiola E., González-Peñas J., Roldán A., Catalán A., González-Ortega I., Toll A., Legido T., Sanchez-Pastor L., Dompablo M., Pomarol-Clotet E., R L.-R., Butjosa A., Rubio E., Lorente-OmeñacaR, Ribeiro M., López-Torres I., León-Quismondo L., Nácher J., Contretas F., Lobo A., Gutiérrez-Fraile M., Sáiz P.A.. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5.600(Q1/2D).
01/04/2022 Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat
Querol-Vilaseca, M, Sirisi, S, Molina-Porcel, L, Molina, B, Pegueroles, J, Ferrer-Raventos, P, Nunez-Llaves, R, Dols-Icardo, O, Balasa, M, Iulita, MF, Blesa, R, Belbin, O, Clarimon, J, Fortea, J, Gelpi, E, Sanchez-Valle, R, Lleo, A. Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2022; 48(3)DOI:10.1111/nan.12781. PMID:34825396. IF:5.000(Q1/2D).